mg m²

Related by string. * MGD . Mg . mgd . MGs . MGS . mgs . mG . MGd . MG . Mgd : Yard Freestyle =-#.# mg dL . mg kg dose . mg tablets . mg mL . mg ml . mg QD . kilogram mg kg . mg sodium . mg capsules . mg kg . mg kg belimumab . MG Rover . mg m . mg dose . -#.# mg dL [002] . RML MG Lola EX# . mg calcium . -#.# mg dL [001] . mg dL . mg dosage / : kg m² . g m² . #cd m² . cd m² brightness . R# m² [001] . R# m² [002] . m² GLA . . cd m² * *

Related by context. Frequent words. (Click for all words.) 75 mcg kg 74 mg/m2 73 mg QD 72 mg m 71 #mg/kg [002] 68 administered subcutaneously 68 fluorouracil 67 mg BID 67 dacarbazine 67 plus prednisone 66 subcutaneous injections 66 nab paclitaxel 66 FOLFIRI 66 mg kg dose 65 FOLFOX 65 mg d 65 mitoxantrone 65 Taxotere R 64 1mg 64 administered orally 64 plus ribavirin 63 μg 63 interferon alfa 63 plus gemcitabine 63 azathioprine 63 mg calcium 63 epirubicin 63 carboplatin 63 peginterferon alfa 2b 63 5 fluorouracil 62 vinorelbine 62 mg kg 62 ceftriaxone 62 peg IFN 62 mg doses 62 relapsed refractory multiple myeloma 62 plus methotrexate 62 cyclophosphamide 62 peginterferon alfa 2a 62 patients receiving ERBITUX 62 Jevtana 62 dose cohorts 62 Median survival 61 dose regimens 61 nM 61 febrile neutropenia 61 Cmax 61 docetaxel 61 2mg 61 #mg dose [003] 61 mg dose 61 events AEs 61 decitabine 61 neoadjuvant 61 azacitidine 61 Taxotere ® 61 zidovudine 61 mg 61 darbepoetin alfa 60 Gemcitabine 60 mcg 60 active comparator 60 #.#mg [003] 60 #mg [003] 60 intravenously administered 60 Copegus 60 RECIST criteria 60 milligram doses 60 leucovorin 60 discontinuations due 60 degarelix 60 inactive placebo 60 vandetanib 60 IU mL 60 pg mL 60 tenofovir disoproxil fumarate 60 placebo p = 59 g trans fats 59 median PFS 59 cytarabine 59 milligrams mg 59 topotecan 59 Ribavirin 59 temsirolimus 59 melphalan 59 unfractionated heparin 59 HCTZ 59 g dietary fiber 59 etoposide 59 hypokalemia 59 neoadjuvant chemotherapy 59 SCH # 59 chemoradiotherapy 59 gemcitabine 59 valacyclovir 59 epoetin alfa 59 log# 59 evaluable 59 adalimumab 59 thymalfasin 59 virologic failure

Back to home page